Click image to enlarge
The R-PLEX platform offers matched sets of antibodies and calibrators for a wide menu of biomarkers. The R-PLEX Mouse PlGF Antibody Set can be used with other MSD components (see "Recommended Components" tab below) to build assays that measure PlGF. These assays can measure PlGF alone or in multiplex panels with other biomarkers.
The Product Inserts for R-PLEX Antibody Sets provide detailed instructions for building assays in several formats. The datasheet for PlGF provides specific information for the components (including calibrator stock concentration), recommended sample types and dilution factors, and representative data for analytical performance. These items and other helpful documents can be found in the "Documentation" tab below.
Related Key Terms
Placental growth factor, PGFL, PLGF, PlGF-2, D12S1900, SHGC-10760, PGF
-
Specifications
-
Recommended Components
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Reproductive Biology
,
Cardiovascular
|
|
|
Analyte(s)
|
|
PlGF
|
|
|
Species
|
|
Mouse
|
|
|
LLOD (Sensitivity)
|
|
2.9 pg/mL
|
|
|
Dynamic Range
|
|
2.9-5,000 pg/mL
|
|
|
Sample Type
|
|
Plasma, Serum
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
18654
|
|
|
UniProt ID(s)
|
|
P49764
|
|
|
Assay Diluent(s)
|
|
Diluent 65
|
|
|
Antibody Diluent(s)
|
|
Diluent 3
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Why do I need other components
Catalog No.
Product Name
Size
R60AM-1
L45SA-1
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Mouse PlGF Antibody Set
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
Mouse PlGF Calibrator
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
SDS
|
|
|
|
Handouts
|
|
|
|
Title
|
Journal
|
Year
|
|
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2 in patients with advanced hepatocellular cancer.
|
|
|
|
Phase I study of Dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma.
|
|
|
|
Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948).
|
|
|
|
Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel anti-angiogenesis agent, in two phase I trials in patients with advanced solid tumors.
|
|
|
|
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer.
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters